HeartSciences (NASDAQ:HSCS – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Monday, August 4th. Analysts expect the company to announce earnings of ($2.51) per share for the quarter.
HeartSciences (NASDAQ:HSCS – Get Free Report) last announced its earnings results on Thursday, July 24th. The company reported ($1.88) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.51) by $0.63. On average, analysts expect HeartSciences to post $-10 EPS for the current fiscal year and $-9 EPS for the next fiscal year.
HeartSciences Stock Down 2.2%
Shares of HSCS opened at $3.05 on Friday. The business’s 50 day moving average is $3.81 and its two-hundred day moving average is $3.50. HeartSciences has a 52-week low of $2.36 and a 52-week high of $6.47. The firm has a market cap of $3.30 million, a price-to-earnings ratio of -0.33 and a beta of 2.57.
Analysts Set New Price Targets
Check Out Our Latest Research Report on HSCS
HeartSciences Company Profile
Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.
Further Reading
- Five stocks we like better than HeartSciences
- Basic Materials Stocks Investing
- Will Hims & Hers Fall Along With Novo Nordisk?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
- Dividend Capture Strategy: What You Need to Know
- Rocket Lab Reports Next Week: Here’s What Investors Should Know
Receive News & Ratings for HeartSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartSciences and related companies with MarketBeat.com's FREE daily email newsletter.